Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 29, 2015 3:12 PM ET

Biotechnology

Company Overview of Catabasis Pharmaceuticals, Inc.

Executive Profile

Kenneth M. Bate MBA

Independent Director, Chairman of Audit Committee and Member of Compensation Committee, Catabasis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 12 different industries.

See Board Relationships
64$88,848

Background

Mr. Kenneth M. Bate, also known as Ken, MBA, serves as a Principal of JSB-Partners, LP. Mr. Bate served as the President of Newport Acquisition Corp., a wholly owned subsidiary of NitroMed Inc. He served as the Chief Executive Officer and President of NitroMed Inc., since January 22 ,2007 and also its Interim Chief Financial Officer since April 11, 2008 until 2009. Mr. Bate is an experienced biotechnology executive having led companies at various stages of development. ...

Corporate Headquarters

One Kendall Square
Cambridge, Massachusetts 02139

United States

Phone: 617-349-1971
Fax: 617-273-2637

Board Members Memberships

2007-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2010-Present
Independent Director, Chairman of Compensation Committee and Member of Audit Committee
2014-Present
Director, Chairman of Compensation Committee and Member of Audit Committee
2014-Present
Independent Director and Member of Audit Committee
2014-Present
Independent Director, Chairman of Audit Committee and Member of Compensation Committee

Education

BA
Williams College
MBA
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$30,000
Total Calculated Compensation$88,848
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Catabasis Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.